Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About the Transplant Diagnostics Market
Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
Technavio’s analysts forecast the global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global transplant diagnostics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of molecular and non-molecular assays. We also consider the revenue generated from pre- and post-transplant diagnostic products and accessories.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Transplant Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bio-Rad Laboratories
• CareDx
• Illumina
• Immucor
• Linkage Biosciences
• Thermo Fisher Scientific
Other prominent vendors
• Abbott Laboratories
• Becton
• Dickinson
• Danaher
• F. Hoffmann-La Roche
• HistoGenetics
• Ortho Clinical Diagnostics
• Oxford Immunotec
• Qiagen
• Siemens
• Sigma-Aldrich
• Tosoh Bioscience
Market driver
• Public awareness of organ donation
• For a full, detailed list, view our report
Market challenge
• Limited technical expertise
• For a full, detailed list, view our report
Market trend
• Product approvals and launches
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
Technavio’s analysts forecast the global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global transplant diagnostics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of molecular and non-molecular assays. We also consider the revenue generated from pre- and post-transplant diagnostic products and accessories.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Transplant Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bio-Rad Laboratories
• CareDx
• Illumina
• Immucor
• Linkage Biosciences
• Thermo Fisher Scientific
Other prominent vendors
• Abbott Laboratories
• Becton
• Dickinson
• Danaher
• F. Hoffmann-La Roche
• HistoGenetics
• Ortho Clinical Diagnostics
• Oxford Immunotec
• Qiagen
• Siemens
• Sigma-Aldrich
• Tosoh Bioscience
Market driver
• Public awareness of organ donation
• For a full, detailed list, view our report
Market challenge
• Limited technical expertise
• For a full, detailed list, view our report
Market trend
• Product approvals and launches
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
